Immunogenicity of Originator and Biosimilar Infliximab: Anti-Drug Antibody Occurence, Cross-Reactivity and Epitope Specificities Across Six Diseases. Analyses from a Norwegian Randomized Switching Trial
AuthID
P-00P-S6X
P-00P-S6X